These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38714448)
1. Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs. Song H; Waheed Abdullah S; Yin S; Dong H; Zhang Y; Tan S; Bai M; Ding Y; Teng Z; Sun S; Guo H Vaccine; 2024 Jul; 42(18):3789-3801. PubMed ID: 38714448 [TBL] [Abstract][Full Text] [Related]
2. A Novel Live Attenuated Vaccine Candidate Protects Against Heterologous Sharma B; Fernandes MHV; de Lima M; Joshi LR; Lawson S; Diel DG Front Immunol; 2019; 10():2660. PubMed ID: 31849928 [No Abstract] [Full Text] [Related]
3. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102 [TBL] [Abstract][Full Text] [Related]
4. Foot-and-mouth disease virus-like particles produced by a SUMO fusion protein system in Escherichia coli induce potent protective immune responses in guinea pigs, swine and cattle. Guo HC; Sun SQ; Jin Y; Yang SL; Wei YQ; Sun DH; Yin SH; Ma JW; Liu ZX; Guo JH; Luo JX; Yin H; Liu XT; Liu DX Vet Res; 2013 Jul; 44(1):48. PubMed ID: 23826638 [TBL] [Abstract][Full Text] [Related]
6. A nanoparticle vaccine based on the VP1 Cao N; Li Y; Zhang H; Liu X; Liu S; Lu M; Hu Z; Tian L; Li X; Qian P Vet Microbiol; 2024 Sep; 296():110198. PubMed ID: 39067145 [TBL] [Abstract][Full Text] [Related]
7. Chimeric virus-like particles elicit protective immunity against serotype O foot-and-mouth disease virus in guinea pigs. Liu X; Fang Y; Zhou P; Lu Y; Zhang Q; Xiao S; Dong Z; Pan L; Lv J; Zhang Z; Zhang Y; Wang Y Appl Microbiol Biotechnol; 2017 Jun; 101(12):4905-4914. PubMed ID: 28365796 [TBL] [Abstract][Full Text] [Related]
8. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease. Dong YM; Cai JC; Chen HT; Chen L Antiviral Res; 2016 Oct; 134():108-116. PubMed ID: 27565990 [TBL] [Abstract][Full Text] [Related]
9. A recombinant multi-epitope trivalent vaccine for foot-and-mouth disease virus serotype O in pigs. Shao J; Liu W; Gao S; Chang H; Guo H Virology; 2024 Aug; 596():110103. PubMed ID: 38781710 [TBL] [Abstract][Full Text] [Related]
11. Chimeric Porcine Parvovirus VP2 Virus-like Particles with Epitopes of South African Serotype 2 Foot-and-Mouth Disease Virus Elicits Specific Humoral and Cellular Responses in Mice. Li Q; Ma X; Shen Y; Dai J; Nian X; Shang X; Chen J; Wubshet AK; Zhang J; Zheng H Viruses; 2024 Apr; 16(4):. PubMed ID: 38675963 [TBL] [Abstract][Full Text] [Related]
12. Artificially designed hepatitis B virus core particles composed of multiple epitopes of type A and O foot-and-mouth disease virus as a bivalent vaccine candidate. Lei Y; Shao J; Zhao F; Li Y; Lei C; Ma F; Chang H; Zhang Y J Med Virol; 2019 Dec; 91(12):2142-2152. PubMed ID: 31347713 [TBL] [Abstract][Full Text] [Related]
14. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus. Li X; Liu R; Tang H; Jin M; Chen H; Qian P Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351 [TBL] [Abstract][Full Text] [Related]
15. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine. Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707 [TBL] [Abstract][Full Text] [Related]
16. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs. Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974 [TBL] [Abstract][Full Text] [Related]
17. Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. Bhat SA; Saravanan P; Hosamani M; Basagoudanavar SH; Sreenivasa BP; Tamilselvan RP; Venkataramanan R Res Vet Sci; 2013 Dec; 95(3):1217-23. PubMed ID: 23969204 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs. Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of vaccine efficacy with 2B/T epitope conjugated porcine IgG-Fc recombinants against foot-and-mouth disease virus. Song BM; Lee GH; Kang SM; Tark D J Vet Med Sci; 2024 Sep; 86(9):999-1007. PubMed ID: 39069487 [TBL] [Abstract][Full Text] [Related]
20. BacMam Expressing Highly Glycosylated Porcine Interferon Alpha Induces Robust Antiviral and Adjuvant Effects against Foot-and-Mouth Disease Virus in Pigs. Kim A; Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM J Virol; 2022 Jun; 96(12):e0052822. PubMed ID: 35604219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]